The C.A.M. Report
Complementary and Alternative Medicine: Fair, Balanced, and to the Point
  • About this web log

    This blog ran from 2006 to 2016 and was intended as an objective and dispassionate source of information on the latest CAM research. Since my background is in pharmacy and allopathic medicine, I view all CAM as advancing through the development pipeline to eventually become integrated into mainstream medical practice. Some will succeed while others fail. But all are treated fairly here.

  • About the author

    John Russo, Jr., PharmD, is president of The MedCom Resource, Inc. Previously, he was senior vice president of medical communications at, a complementary and alternative medicine website.

  • Common sense considerations

    The material on this weblog is for informational purposes. It is not medical advice or counsel. Be smart, consult your health professional before using CAM.

  • Recent Posts

  • Recent Comments

    Hybrid broccoli

    The Financial Times reports, “A new hybrid variety richer in chemicals linked to a reduced risk of cancer and cardiovascular problems goes on sale on Tuesday” in the UK.

    Here’s what we know.

    • The hybrid broccoli (called Beneforté) was developed by British academics and involves no genetic modification.
    • Beneforté contains up to 3 times the levels of glucoraphanin, which some research suggests lowers the risk of aggressive prostate cancer and heart disease.
    • The new broccoli will cost £1.49 ($2.00) each, compared with £1 ($1.32) for existing varieties.

    The bottom line?

    More on the history of functional foods and what distinguishes them from nutraceuticals can be found here.

    10/4/11 21:27 JR

    Leave a Comment

    You must be logged in to post a comment.